Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Clinical and Translational Allergy|July 25, 2023
In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticariaSherezade Moñino-Romero, Pavel Kolkhir, Zsolt Szépfalusi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2025
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysisFranz J Legat, Shawn G Kwatra, Adam Reich, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2023
Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE StudyHanna Bonnekoh, Jannis Jelden-Thurm, Anastasiia Allenova, et al.
JAMA Dermatology|November 27, 2024
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 TrialSonja Ständer, Gil Yosipovitch, Franz J Legat, et al.
Acta Dermato-Venereologica|December 15, 2020
Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and SatisfactionManuel P Pereira, Claudia Zeidler, Joanna Wallengren, et al.
Frontiers in Medicine|June 27, 2022
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin DiseasesHideyuki Ujiie, David Rosmarin, Michael P Schön, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2021
A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in miceKatharina Wolf, Helen Kühn, Felicitas Boehm, et al.
The New England Journal of Medicine|October 3, 2019
Ligelizumab for Chronic Spontaneous UrticariaMarcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Allergy|July 24, 2024
Disease modification in chronic spontaneous urticariaMarcus Maurer, Pavel Kolkhir, Manuel P Pereira, et al.
Clinical and Translational Allergy|August 7, 2025
Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?Annika Gutsche, Pascale Salameh, Samad S Jahandideh, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Clinical and Translational Allergy|July 25, 2023
In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticariaSherezade Moñino-Romero, Pavel Kolkhir, Zsolt Szépfalusi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2025
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysisFranz J Legat, Shawn G Kwatra, Adam Reich, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2023
Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE StudyHanna Bonnekoh, Jannis Jelden-Thurm, Anastasiia Allenova, et al.
JAMA Dermatology|November 27, 2024
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 TrialSonja Ständer, Gil Yosipovitch, Franz J Legat, et al.
Acta Dermato-Venereologica|December 15, 2020
Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and SatisfactionManuel P Pereira, Claudia Zeidler, Joanna Wallengren, et al.
Frontiers in Medicine|June 27, 2022
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin DiseasesHideyuki Ujiie, David Rosmarin, Michael P Schön, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2021
A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in miceKatharina Wolf, Helen Kühn, Felicitas Boehm, et al.
The New England Journal of Medicine|October 3, 2019
Ligelizumab for Chronic Spontaneous UrticariaMarcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Allergy|July 24, 2024
Disease modification in chronic spontaneous urticariaMarcus Maurer, Pavel Kolkhir, Manuel P Pereira, et al.
Clinical and Translational Allergy|August 7, 2025
Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?Annika Gutsche, Pascale Salameh, Samad S Jahandideh, et al.
Pageof 26